NPSA (UK's National Patient Safety Agency) resignation sparks policy speculation:
This article was originally published in Clinica
The UK's National Patient Safety Agency's director of communications, Steve Wedgwood, has resigned. The agency would not comment on speculation that his departure might be associated with the recent debate over policy concerning the publication of raw data on adverse events. "The work of the NPSA is continuing and policy has not changed," said a spokesperson, in response to suggestions that Mr Wedgwood's departure might reflect further discord over this issue. The government recently found itself in deep water over its handling of the damning results of a pilot into adverse event reporting.
You may also be interested in...
The C-suite leaders schemed to falsely record shipments of unwanted products to distributors as sales so the company could meet revenue projections, the government charged.
Gallium has been approved as a diagnostic agent by the US agency to help early detection of prostate cancer spread in patients who qualify for treatment with surgery or radiation therapy.
A joint report by the US Government Accountability Office and the National Academy of Sciences slams the FDA for dawdling on final software as a medical device rules.